HPHPA

If your gut is harboring an overgrowth of certain Clostridia bacteria, the evidence may show up in your urine long before it shows up on any standard test. HPHPA (3-(3-hydroxyphenyl)-3-hydroxypropionic acid) is one of the few measurable footprints these bacteria leave behind, and its presence has been tied to neuropsychiatric symptoms, recurrent gut infection, and broader changes in how your body handles certain amino acids.

This is a research-stage marker, not a routine clinical test. There are no standardized cutoffs, and a single reading carries less weight than a trend over time. Still, for people exploring the connection between gut bacteria and brain, behavior, or chronic gut symptoms, it offers a window that almost no other test provides.

What HPHPA Actually Is

HPHPA is a small organic acid related to the amino acid phenylalanine. It does not come from your own cells. Research describes it as a byproduct made by anaerobic Clostridium species (gut bacteria that thrive without oxygen) as they break down certain amino acids in your intestine. Once made, it travels through your bloodstream and is filtered out by your kidneys, which is why it can be measured in urine.

Researchers have proposed that HPHPA is a probable byproduct of m-tyrosine, an unusual cousin of the amino acid tyrosine. In animal studies, m-tyrosine depletes brain catecholamines (chemical messengers like dopamine and norepinephrine that influence mood, focus, and movement). This proposed pathway is what links HPHPA in the gut to potential effects on the brain, though the brain effects themselves have only been shown in animals.

What the Gut Connection Suggests

A higher HPHPA reading suggests that Clostridia bacteria in your gut are unusually active or overgrown. The most direct human evidence comes from a published case in which a patient with acute schizophrenia had urinary HPHPA roughly 300 times the median value seen in healthy adults. After oral vancomycin (an antibiotic that targets gut Clostridia), the level fell sharply and the psychotic symptoms remitted in parallel.

The same research reported elevated HPHPA in children with autism compared with age- and sex-matched controls, and in an adult with recurrent Clostridioides difficile diarrhea. The pattern across these very different conditions points to one shared theme: bacterial overgrowth in the gut producing a measurable chemical signature in urine.

Neuropsychiatric Associations

The strongest signal in the published research links elevated urinary HPHPA to two neuropsychiatric conditions: autism spectrum disorder and schizophrenia. In both, levels were higher than in healthy controls, and in the schizophrenia case, the level tracked closely with symptoms.

This does not mean HPHPA causes these conditions, or that lowering it treats them. The evidence is from small studies and a single dramatic case report, not from large trials. What it does mean is that for someone exploring whether the gut-brain axis is contributing to their symptoms, HPHPA is one of the few specific microbial markers with any human evidence behind it.

Recurrent Clostridia-Related Gut Symptoms

In one published case, an adult with recurrent Clostridioides difficile diarrhea also had elevated urinary HPHPA. This fits the broader hypothesis that the marker rises when Clostridia species (the same family that causes C. difficile infection) are unusually active. For someone with a history of recurrent gut infection, persistent diarrhea after antibiotics, or unexplained gut symptoms with suspected dysbiosis, an elevated HPHPA reading adds one more piece of evidence pointing toward the gut microbiome.

Other Conditions Where HPHPA Has Been Studied

In an observational study of pulmonary arterial hypertension (a serious form of high blood pressure in the lungs), 43 patients and 37 controls had their plasma and urine analyzed. Urinary HPHPA appeared as one of eight metabolites that together distinguished patients from controls with about 91% accuracy. It was part of a panel, not a standalone marker, and the direction and mechanism were not specified.

A closely related metabolite, 3-hydroxyphenylpropionic acid, has been correlated with the severity of protein leakage in the urine (a sign of kidney damage) in people with type 2 diabetes and biopsy-confirmed kidney disease. This is suggestive but indirect: it concerns a related, not identical, molecule.

Why One Reading Is Not Enough

HPHPA sits firmly in research territory. There are no standardized clinical cutpoints, and labs may use different methods that produce different numbers. The biggest weakness of a single reading is that it captures one moment in your gut chemistry, which can shift with diet, recent antibiotic or probiotic use, and the natural variability of the microbiome.

Trending is more useful than a snapshot. Get a baseline now, retest in 3 to 6 months if you are making changes aimed at gut health, and at least annually after that. If you take a course of antibiotics or make a major dietary change, a follow-up test can show whether your gut bacterial output has actually shifted, rather than guessing from symptoms alone.

When Results Can Be Misleading

A single HPHPA reading reflects what your gut bacteria were doing in the days leading up to the test, not a fixed trait. Several things can distort the picture:

• Recent antibiotics: in the one published case where vancomycin was used, urinary HPHPA fell sharply within days. Any antibiotic that affects gut bacteria can shift levels temporarily.
• Dietary polyphenols: foods like grape seed extract, green tea, and coffee feed gut bacteria that produce closely related phenolic acids. Studies on related molecules show urinary excretion can rise after polyphenol-rich meals.
• Collection timing and dilution: urine concentration varies through the day. Results are typically reported relative to creatinine to adjust for this, but very dilute or very concentrated samples can still skew the interpretation.
• Lab method differences: because HPHPA does not have a single standardized assay, numbers from different labs are not directly comparable.

What to Do With an Out-of-Pattern Result

If your HPHPA reading is unexpectedly high, the next step is not to treat the number. It is to put the result in context. Retest after a few months to confirm the trend, ideally with the same lab and method. If the elevation persists, consider pairing this test with a comprehensive stool analysis to look directly at Clostridia and broader microbial balance, and an organic acids panel if you have not already done one.

For people with neuropsychiatric symptoms, persistent gut issues, or a history of recurrent C. difficile, a discussion with a clinician familiar with the gut-brain axis (a gastroenterologist, integrative medicine physician, or psychiatrist with this expertise) is the right path. Do not start antibiotics based on a urine number alone. The published case where vancomycin lowered HPHPA was in a person with overt psychosis and other clinical findings, not an asymptomatic test result.